跳至主要内容
临床试验/NCT03018496
NCT03018496已完成不适用

Investigating the Effects of Beta-Hydroxy-Beta-Methylbutyrate on Glucose Handling in Older and Younger Men.

University of Nottingham2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2017年1月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
2
主要终点
Matsuda Index of insulin sensitivity

研究概览

简要总结

This study intends to examine the effect of a commercially available nutritional supplement, Beta-hydroxy-beta-methylbutyrate(HMB) on whole-body responses to a sugar load.

详细描述

One change associated with human aging is a reduction in "fitness", both in terms of how far or quickly a person can run/cycle/swim and also in how well their blood vessels work. Additionally a person's metabolic fitness decreases; this is how well the body copes with nutrition and is why, for example, older people have a higher risk of diseases like type 2 diabetes. Previous studies have shown that as people become less fit, they are at increased risk of suffering a complication whilst undergoing surgery. It has also been shown that measuring how fit someone is, is better at predicting the risk of a surgical complication than purely using a person's age alone. Lots of research has shown that exercise can potentially reverse some of the age-related declines in fitness, however most has used long sessions of continuous exercise over a long period of time. High-intensity interval training (HIT), whereby people cycle on an exercise bike very hard for a minute, followed by a short rest, repeated over the course of 15 minutes can rapidly improve a person's fitness. However not everyone will be able to, or indeed want to participate in exercise this strenuous; therefore this research seeks to explore whether other options, such as dietary supplements can improve aspects of fitness

This study intends to examine the effect of giving a dietary supplement on the way a person's body handles the glucose (from carbohydrates/ sugars) in a meal. Previous work has shown that taking a beta-hydroxy beta-methyl butyrate (HMB) supplement may improve may improve a patient's response to glucose, however the evidence is not clear. HMB is a commercially available nutritional supplement providing a compound that the body produces each time protein is consumed, and is most commonly used by bodybuilders to help gain muscle.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Healthy volunteers
  • Aged 18-35 or 65-85

排除标准

  • Current participation in a formal exercise regime
  • A BMI < 18 or > 32 kg·m2
  • Active cardiovascular disease:
  • o uncontrolled hypertension (BP > 160/100), angina, heart failure (class III/IV), Significant arrhythmia, right to left cardiac shunt, recent cardiac event
  • Taking beta-adrenergic blocking agents,
  • Cerebrovascular disease:
  • o previous stroke, aneurysm (large vessel or intracranial), epilepsy
  • Respiratory disease including:
  • o pulmonary hypertension, significant COPD, uncontrolled asthma,
  • Metabolic disease:
  • o hyper and hypo parathyroidism, untreated hyper and hypothyroidism, Cushing's disease, type 1 or 2 diabetes
  • Active inflammatory bowel or renal disease
  • Malignancy
  • Clotting dysfunction
  • Significant musculoskeletal or neurological disorders
  • Family history of early (<55y) death from cardiovascular disease

研究组 & 干预措施

Older Men

Experimental

Healthy male adults aged 18-35 Subjects will receive both HMB and placebo on separate visits in a crossover fashion

干预措施: Beta-Hydroxy-Beta-Methylbutyrate (Dietary Supplement)

Younger Men

Experimental

Healthy male adults aged 65-85 Subjects will receive both HMB and placebo on separate visits in a crossover fashion

干预措施: Beta-Hydroxy-Beta-Methylbutyrate (Dietary Supplement)

Older Men

Experimental

Healthy male adults aged 18-35 Subjects will receive both HMB and placebo on separate visits in a crossover fashion

干预措施: Placebo (Other)

Younger Men

Experimental

Healthy male adults aged 65-85 Subjects will receive both HMB and placebo on separate visits in a crossover fashion

干预措施: Placebo (Other)

结局指标

主要结局

Matsuda Index of insulin sensitivity

时间窗: 180 minutes after a 75g oral glucose load

Assessed from arterialised venous blood samples

Cederholm index of insulin sensitivity

时间窗: 180 minutes after a 75g oral glucose load

Assessed from arterialised venous blood samples

次要结局

  • Area-Under-Curve Insulin Concentration(180 minutes after a 75g oral glucose load)
  • Area-Under-Curve Glucose Concentration(180 minutes after a 75g oral glucose load)
  • Femoral Artery Blood flow(15 minutes, 60 minutes and 120 minutes after a 75g oral glucose load)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验